insulin, whereas the response to LPA was similar to that observed in cells expressing wild-type eNOS. Moreover, production of NO in response to insulin was blocked by coexpression of an inhibitory mutant of Akt, whereas the response to LPA was unaffected. Phosphorylation of eNOS at Ser 1179 was observed only in response to treatment with insulin, but not with LPA. Interestingly, platelet-derived growth factor treatment of cells activated Akt but not eNOS. Results from human vascular endothelial cells were qualitatively similar to those obtained in transfected NIH-3T3 IR cells, although the magnitude of the responses was smaller. We conclude that insulin regulates eNOS activity using a Ca 2؉ -independent mechanism requiring phosphorylation of eNOS by Akt. Importantly, phosphorylation-dependent mechanisms that enhance eNOS activity can operate independently from Ca 2؉
Insulin has vasodilator effects, in addition to its well known metabolic actions, that depend on production of nitric oxide (NO) in the vascular endothelium (1, 2) . We previously demonstrated that key signaling molecules mediating metabolic actions of insulin, such as the insulin receptor tyrosine kinase, PI 1 3-kinase, and Akt (3), are also necessary for insulin to stimulate production of NO in human vascular endothelial cells (4, 5) . Thus, one physiological role of insulin action in vascular endothelium may be to couple regulation of hemodynamic homeostasis with metabolic homeostasis (6) . Moreover, abnormalities in insulin signaling in endothelial cells related to metabolic insulin resistance may help to explain the frequent association between hypertension and diabetes (6) . Therefore, it is of great interest to elucidate the precise mechanisms whereby insulin signaling regulates the activity of endothelial nitric-oxide synthase (eNOS). eNOS contains reductase and oxygenase domains that are joined by a calmodulin binding site (7) . Regulation of eNOS activity typically involves mobilization of intracellular Ca 2ϩ , subsequent binding of Ca 2ϩ /calmodulin to the enzyme, and displacement of caveolin-1 from eNOS (8 -11) . This promotes transfer of electrons from the reductase domain to the oxygenase domain, catalyzing the formation of NO from L-arginine (for reviews, see Refs. 7 and 12). Treatment of neurons and pancreatic ␤-cells with insulin has been reported to mobilize intracellular Ca 2ϩ stores (13, 14) . However, it is not clear whether insulin-stimulated activation of eNOS is mediated by Ca 2ϩ , because insulin is not a classical agonist for modulation of intracellular Ca 2ϩ in endothelium. Furthermore, even though eNOS is often regarded as a strictly Ca 2ϩ /calmodulindependent enzyme, there is a growing body of evidence that activation of eNOS in endothelium may be independent of Ca 2ϩ for stimuli such as IGF-1 (15) , estrogen (16) , shear stress (17) , and isometric contraction (18) . Thus, additional Ca 2ϩ -independent mechanisms regulating eNOS activity may exist (19) . Indeed, several groups have recently reported that Akt can phosphorylate human eNOS at Ser 1177 (Ser 1179 in bovine eNOS), resulting in increased eNOS activity (20 -22) . Previously, we had identified a critical role for Akt in the insulin-signaling pathway responsible for production of NO in endothelium but had not studied the direct effects of Akt in regulating phosphorylation or enzymatic activity of eNOS in response to insulin (5) . In the present study, we investigated whether mechanisms in which insulin regulates eNOS activity involve Ca 2ϩ or phosphorylation of eNOS by Akt. Our results suggest that insulin-stimulated activation of eNOS is independent of Ca 2ϩ and that phosphorylation of eNOS on Ser 1179 by Akt is necessary for insulin to activate eNOS. Importantly, we also found that phosphorylation-dependent regulation and Ca 2ϩ -dependent regulation of eNOS may be separable and functionally independent.
MATERIALS AND METHODS

Plasmid Constructs
The pCIS2 mammalian expression vector (23) was the parent vector for all constructs.
pCIS2-RFP-The XhoI/NotI fragment containing cDNA for red fluorescent protein obtained from pDsRed1-1 (CLONTECH Laboratories Inc., Palo Alto, CA) was subcloned into pCIS2.
eNOS-WT-The cDNA for bovine eNOS (a gift from Dr. Thomas Michel) was subcloned into pCIS2.
eNOS-S1179A-A point mutant of eNOS-WT disrupting the Akt phosphorylation site was constructed by site-directed mutagenesis with the MORPH kit (Eppendorf-5 Prime, Boulder, CO) and the mutagenic oligonucleotide (5Ј-CGT ACC CAG GCC TTT TCC CTG-3Ј). This mutation introduced a new StuI site and was confirmed by direct sequencing.
Akt-K179A-The cDNA for the kinase-inactive mutant of Akt in pCIS2 was as described (24) .
Akt-AAA-The cDNA for Akt in pCIS2 containing point mutations K179A, T308A, and S473A was as described (25) .
Cell Culture and Transfection
NIH-3T3 fibroblasts stably expressing human insulin receptors (NIH-3T3 IR ) (26) were seeded into 35-mm tissue culture dishes (Delta TC3, Bioptechs, Inc., Butler, PA) and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin G (100 units/ml), and streptomycin (100 g/ml) at 37°C in a humid atmosphere with 5% CO 2 . Cells at 60% confluence were transiently cotransfected with 0.1 g of pCIS2-RFP, 0.45 g of an eNOS construct, and 0.45 g of either pCIS2 or an Akt construct using LipofectAMINE Plus (Life Technologies, Inc.). Human umbilical vein endothelial cells (HUVEC) and bovine aortic endothelial cells in primary culture (Clonetics Corp., San Diego, CA) were grown in EGM-2 as described (4, 5) and used at passages 3-4. For immunoblotting experiments, cells were serum-starved overnight prior to initiation of the experiments.
Measurement of NO Production in Cells
One day after transfection, NIH-3T3 IR cells were serum-starved for 2 h after being washed three times with Dulbecco's modified Eagle's medium-A (Dulbecco's modified Eagle's medium without red phenol, 15 mm Hepes, pH 7.4, 0.1% bovine serum albumin). L-arginine (100 M) was added 1 h prior to each study. Untransfected or transiently transfected endothelial cells grown at 95% confluence were serum-starved for 2 h in EBM-A (red phenol-free endothelial basal media from Clonetics Corp supplemented with 1% platelet-deprived horse serum (Sigma) and 100 M L-arginine). Serum-starved cells were first loaded with the NO-reactive dye 4,5-diaminofluorescein diacetate (DAF-2 DA; Calbiochem) (final concentration, 3 M; 20 min, 37°C). DAF-2 DA is a cellpermeable compound that is converted to DAF-2 by intracellular esterases and forms a triazole derivative in the presence of NO that emits light at 515 nm upon excitation at 489 nm in proportion to the amount of NO present (27, 28) . After loading, cells were rinsed three times in Dulbecco's modified Eagle's medium-A supplemented with 100 M Larginine or EBM-A, kept in the dark, and maintained at 37°C with a warming stage (Bioptechs, Inc.) on a Zeiss Axiovert S100 TV inverted microscope (Carl Zeiss Inc., Thornwood, NY) equipped with an argon laser, PentaMAX camera (Princetown Instruments Inc., Trenton, NJ), and appropriate filters for fluorescence microscopy. In some experiments, L-NAME (100 M) was added 20 min before loading with DAF-2 DA. In other experiments, 10 M BAPTA tetrakis(acetoxymethyl ester) (Calbiochem) was added along with DAF-2 DA. To identify transiently transfected cells, RFP expression was visualized by emission of red light (583 nm) upon excitation at 558 nm. Typically, two to five transfected cells were identified in a field of view at ϫ 32 magnification. Cells were then treated with insulin, lysophosphatidic acid (LPA), or PDGF-BB, and NO production was visualized by emission of green light (515 nm) upon excitation at 489 nm over a period of up to 9 min. Because the DAF-2 dye undergoes significant photobleaching, we maintained cells in the dark and only exposed them to a light intensity of 20% for 3 s for each image captured. Green fluorescence intensity was quantified using IP Labs Software (Scanalytics Inc., Fairfax, VA) to integrate intensity over all pixels within the boundary of each transfected cell. Data for each experiment were normalized to a reference image of the basal state.
Immunoblotting
Cell lysates were prepared using 100 l of lysis buffer (100 mM NaCl, 20 mM Hepes, pH 7.9, 1% Triton X-100, 1 mM Na 3 VO 4 , 4 mM sodium pyrophosphate, 10 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, and the complete protease inhibitor mixture (Roche Molecular Biochemicals). Samples (45 g of total protein) were separated by 8% SDS-polyacrylamide gel electrophoresis and immunoblotted with antibodies against eNOS (Transduction Laboratories, Lexington, KY), Akt (Upstate Biotechnology, Inc., Lake Placid, NY), phospho-eNOS (PSer 1177 , Cell Signaling Technology, Beverly, MA), or phospho-Akt (PSer 473 , New England Biolabs, Beverly, MA) according to standard methods. For immunoblotting experiments with the phospho-eNOS antibody, okadaic acid (100 nM) was added to the lysis buffer.
RESULTS
Insulin Stimulates Production of NO in NIH-3T3
IR Cells Transiently Transfected with eNOS-To study the mechanisms by which insulin activates eNOS in a minimal system, we transiently cotransfected eNOS and RFP into NIH-3T3 IR cells and loaded cells with the NO-specific fluorescent dye DAF-2 (Fig. 1A) . Cells expressing eNOS were identified by coexpression of RFP (detected by emission of red light at 583 nm upon excitation at 558 nm) (Fig. 1B) . When these cells were excited with light at 489 nm, insulin caused a rapid, dose-dependent, saturable ϳ50-fold increase in green fluorescence at 515 nm (ED 50 of ϳ50 nM), indicative of a rise in intracellular NO ( 
Insulin-stimulated Activation of eNOS Is Ca 2ϩ
-independenta peak at 2 min followed by a rapid return to basal levels by 3 min (Fig. 2 , A, C, and E, closed triangles). Taken together, these data suggest that our strategy of coexpressing eNOS and RFP in NIH-3T3
IR cells in conjunction with the use of DAF-2 DA is a useful model system for understanding how insulin signaling regulates eNOS activity.
Insulin-stimulated Activation of eNOS Requires Ser 1179 -We next compared cells expressing wild-type eNOS with cells expressing eNOS-S1179A (disrupted Akt phosphorylation site). Strikingly, in contrast to cells expressing wild-type eNOS (Fig.  2 , A, C, and E, closed triangles), there was no detectable production of NO in response to insulin in cells expressing eNOS-S1179A (Fig. 2 , B, D, and E, open triangles), despite comparable expression of wild-type and mutant eNOS in the two groups of cells (Fig. 2F) . Thus, the Akt phosphorylation site at Ser 1179 appears to be absolutely essential for regulation of eNOS activity by insulin.
Insulin-stimulated Activation of eNOS Does Not Require Ca 2ϩ -Because eNOS is typically regulated by changes in intracellular Ca 2ϩ , we inquired whether Ca 2ϩ is also involved in the regulation of eNOS activity by insulin. When NIH-3T3 IR cells cotransfected with eNOS and RFP were treated with LPA (a phospholipid growth factor that mobilizes intracellular Ca 2ϩ ), we observed a rapid rise in production of NO that peaked at 30 s and slowly decreased to basal levels by 3 min (Fig. 3, B-D and K, closed circles) . When these same cells were subsequently treated with insulin, we observed a comparable stimulation of NO production with a distinct time course (peak at 2 min, back to basal by 3 min) (Fig. 3, D , E, and K, closed triangles). Consistent with the importance of Ca 2ϩ in regulating eNOS activity, LPA-induced production of NO was completely blocked in cells pretreated with BAPTA (calcium chela- 
NIH-3T3
IR cells transiently cotransfected with pCIS2-RFP and either eNOS-WT (A and C) or eNOS-S1179A (B and D) were treated as described in the legend to Fig. 1 . Transfected cells (expressing RFP) were identified by emission of red light (583 nm) upon excitation at 558 nm (A and B). Two min after the addition of insulin (500 nM), production of NO was visualized by emission of green light (515 nm) upon excitation at 489 nm in cells transfected with eNOS-WT (C) or eNOS-S1179A (D). E, the time course of relative green fluorescence intensity after insulin stimulation was plotted as the mean Ϯ S.E. of 12 independent experiments for eNOS-WT (OE) and 7 independent experiments for eNOS-S1179A (‚). F, anti-eNOS immunoblot of cell lysates derived from transfected cells demonstrated comparable expression of eNOS-WT and eNOS-S1179A. Ctrl, control. (Fig. 3, G-I and K, open circles) . Nevertheless, when these BAPTA-treated cells were subsequently stimulated with insulin, we observed a significant increase in production of NO comparable with that seen in cells not pretreated with BAPTA (Fig. 3, I , J, and K, open triangles). We observed similar results when insulin was added first and LPA treatment was second (data not shown).
Insulin-stimulated Activation of eNOS Is
Interestingly, insulin treatment stimulated the phosphorylation (and presumably activation) of Akt in both the absence and presence of BAPTA (Fig. 3L, lanes 4, 5, 8 , and 9) whereas LPA treatment did not (Fig. 3L, lanes 2, 3, 6, and 7) . Moreover, when we immunoblotted cell lysates with a phosphospecific antibody directed against the Akt phosphorylation site in eNOS, only insulin treatment, but not LPA treatment, resulted in a significant increase in phosphorylation of wild-type eNOS at Ser 1179 (Fig. 4, top panel, lanes 2-4) . No band was detected in anti-phospho-eNOS immunoblots of lysates derived from insulin-stimulated cells expressing the mutant eNOS-S1179A, demonstrating the specificity of the phospho-eNOS antibody (Fig. 4, top panel, lane 5) . Comparable levels of phosphorylated Akt were detected in response to insulin stimulation of cells expressing either eNOS-WT or eNOS-S1179A (Fig. 4, lower  panel, lanes 4 and 5) . Taken together, the results from Figs. 3 and 4 strongly suggest that insulin-stimulated activation of eNOS is independent of changes in intracellular Ca 2ϩ and that LPA-stimulated activation of eNOS is independent of Akt activation. Thus, alternative mechanisms for regulation of eNOS activity by insulin must exist.
Ser 1179 and Akt Are Required for Activation of eNOS by Insulin but Not by LPA-To determine whether Ca 2ϩ -dependent and phosphorylation-dependent mechanisms for regulating eNOS activity are separable, NIH-3T3 IR cells expressing eNOS-S1179A were sequentially treated with insulin and LPA. As demonstrated above (Fig. 2) , insulin was unable to stimulate the production of NO in these cells (Fig. 5A, open triangles) . Nevertheless, subsequent treatment with LPA stimulated significant production of NO that was comparable with that seen in cells expressing wild-type eNOS (Fig. 5A, open  circles) . Similar results were obtained when cells were treated first with LPA and then with insulin (data not shown). Thus, Ser 1179 is critical for activation of eNOS by insulin but is not required for activation of eNOS by LPA. We next examined cells cotransfected with wild-type eNOS and Akt-K179A (inhibitory Akt mutant) to determine the role of Akt in LPA-and insulin-mediated activation of eNOS. Similar to results obtained with eNOS-S1179A, production of NO in response to insulin treatment was blocked by coexpression of the mutant Akt (Fig. 5B, closed triangles) , whereas the ability of LPA to stimulate production of NO was unaffected by the inhibitory mutant (Fig. 5B, closed circles) . Similar results were obtained using Akt-AAA (another inhibitory mutant of Akt) (data not shown). These findings support the concept that insulin-stimulated activation of eNOS requires phosphorylation of eNOS by Akt. However, the regulation of eNOS activity by Ca 2ϩ -dependent mechanisms does not require this phosphorylation.
To determine whether effects of insulin and LPA on activation of eNOS were synergistic, we compared simultaneous stimulation of cells with LPA and insulin with subsequent addition of LPA and insulin alone (Fig. 6) . Interestingly, the magnitude of the rise in intracellular NO in response to concurrent treatment with LPA and insulin was similar to that observed with either LPA or insulin alone. However, the time course of NO production in response to combination treatment resembled addition of the two time courses for individual treatment. That is, simultaneous LPA and insulin treatment resulted in a rapid rise in NO at 30 s followed by sustained production of NO over the next 90 s and then a rapid decrease back to basal levels by 2.5 min.
Activation of Akt Is Not Sufficient for Activation of eNOSBecause phosphorylation of eNOS by Akt was necessary for activation of eNOS by insulin, we wondered whether activation of Akt would be sufficient. In NIH-3T3 IR cells expressing wildtype eNOS, little, if any, increase in intracellular NO was observed in response to PDGF stimulation (Fig. 7A, closed  squares) , whereas the production of NO in response to insulin in the same cells resembled the time course previously illustrated (Fig. 7A, closed triangles) . Interchanging the order of PDGF and insulin stimulation did not alter these results (data not shown). Similarly, insulin, but not PDGF, stimulated phosphorylation of eNOS at Ser 1179 (Fig. 7B, upper panel) . Nevertheless, both PDGF and insulin stimulated comparable phosphorylation and activation of endogenous Akt (Fig. 7B, lower  panels) . Thus, stimulation of Akt activity per se was not sufficient to phosphorylate and activate eNOS.
Insulin-and LPA-stimulated Activation of eNOS in Vascular Endothelial Cells-To determine whether results obtained with our minimal system of NIH-3T3
IR cells transiently transfected with eNOS were relevant to a physiological cell type, we repeated key experiments using HUVEC and bovine aortic endothelial cells in primary culture (Fig. 8) . In untransfected HUVEC, the time course and dynamics for LPA-and insulinstimulated production of NO were similar to those obtained in transfected NIH-3T3 IR cells, although the absolute magnitude of the response was 6 -7 times lower (Fig. 8A) . Similar results were obtained in untransfected bovine aortic endothelial cells (data not shown). Importantly, pretreatment of HUVEC with BAPTA significantly inhibited production of NO in response to 
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LPA (Fig. 8B, closed squares) , without affecting the response to insulin (Fig. 8B, closed triangles) . Finally, HUVEC overexpressing either eNOS-S1179A or AKT-AAA (identified by coexpression of RFP) produced NO in response to LPA stimulation (Fig. 8, C and D, closed squares) but not in response to insulin stimulation (Fig. 8, C and D, closed triangles) . Thus, our results in endothelial cells in primary culture agree qualitatively with our results in a minimal system. That is, insulin-stimulated production of NO in vascular endothelium requires phosphorylation of eNOS on Ser 1179 by Akt and is independent of intracellular calcium mobilization. Moreover, LPA-mediated activation of eNOS is calcium-dependent but independent of Akt and phosphorylation of eNOS at Ser 1179 .
DISCUSSION
The critical role of eNOS in hemodynamic homeostasis has been unequivocally demonstrated by the presence of hypertension in eNOS "knockout" mice (29, 30) . The observations that IRS-1 knockout mice are hypertensive (31) whereas eNOS knockout mice are insulin-resistant (32) suggest that insulin signaling and regulation of eNOS activity may intersect and contribute importantly to regulation of both metabolic and cardiovascular physiology. We have recently shown that striking parallels exist between insulin signaling pathways related to glucose uptake in adipose tissue and insulin signaling pathways related to production of NO in vascular endothelium (3, 6) . In particular, we found that the insulin receptor tyrosine kinase, PI 3-kinase, and Akt play important roles in both of these processes, whereas Ras pathways and PDGF-stimulated activation of Akt do not (4, 5, (33) (34) (35) . Thus, it is of great interest to determine the precise mechanisms underlying insulin-stimulated activation of eNOS because this may contribute to understanding the pathophysiological relationships between diabetes and hypertension.
Insulin-stimulated Activation of eNOS-The NO-specific fluorescent dye DAF-2 has previously been employed to quantitatively study intracellular production of NO in a variety of cell types that normally express nitric-oxide synthase isoforms (27, 28, 36, 37) . The increase in fluorescence of DAF-2 is proportional to the amount of intracellular NO present (27) . We have extended this method by transiently cotransfecting genes encoding RFP and eNOS and other genes of interest into NIH-3T3 IR cells that do not normally express endogenous eNOS. Our cotransfection efficiency under these conditions is nearly 100% (5), and expression of RFP did not interfere with the fluorescent signal from DAF-2. Thus, expression of RFP allowed us to identify cotransfected cells and evaluate the functional consequences of various transgenes on coupling of insulin receptor signaling with activation of eNOS. In this minimal system, only cells expressing eNOS produced NO in response to insulin stimulation. The specificity of our approach was further demonstrated by the lack of DAF-2 fluorescence in insulinstimulated cells pretreated with L-NAME. The rapid, dose-dependent effect of insulin in stimulating production of NO in NIH-3T3 IR cells expressing eNOS was consistent with data we previously obtained in human vascular endothelial cells using an NO-specific electrode (4, 5) . Indeed, the ED 50 for insulinstimulated production of NO in NIH-3T3 IR cells evaluated using DAF-2 was ϳ10 times less than that reported for endothelial cells with the NO-specific electrode (4, 5) . This most likely reflects the improved sensitivity of DAF-2 over the electrodebased method as well as an ability to carry out experiments at 37°C rather than at room temperature. Moreover, we validated our model system by using vascular endothelial cells in primary culture to generate qualitatively similar results. Thus, our novel approach is useful for evaluating mechanisms for insulin to regulate the activity of eNOS in intact cells as well as for generating physiologically relevant insights.
Akt Is Necessary, but Not Sufficient, for Activation of eNOS by Insulin-We previously demonstrated that both PI 3-kinase and Akt are necessary for insulin-stimulated production of NO in human vascular endothelial cells (5) . Recently, several groups independently identified an Akt phosphorylation site on eNOS that regulates its activity (20 -22) . In the present study, we show that insulin, but not LPA, stimulated phosphorylation and activation of both Akt and eNOS. The phosphorylation of eNOS at Ser 1179 in response to insulin was dependent on Akt. Moreover, insulin was able to stimulate production of NO from wild-type eNOS but not from eNOS with a point mutation at the Akt phosphorylation site (eNOS-S1179A) or from wild-type eNOS in the presence of an inhibitory Akt mutant. These data indicate that insulin-stimulated activation of Akt is absolutely required for phosphorylation of eNOS at Ser 1179 and subse- 
FIG. 7. Activation of Akt is not sufficient for activation of eNOS. A, NIH-3T3
IR cells transiently cotransfected with pCIS2-RFP and eNOS-WT were treated as described under "Materials and Methods," and the time course of relative green fluorescence intensity in transfected cells (identified by expression of RFP) after sequential PDGF (f) and insulin (OE) treatment was plotted as the mean Ϯ S.E. of five independent experiments. B, phosphorylation of eNOS and activation of endogenous Akt by PDGF or insulin was assessed by immunoblotting cell lysates derived from NIH-3T3 IR cells in the basal state and after treatment with PDGF (100 ng/ml, 2 min) or insulin (500 nM, 2 min) using antibodies against eNOS and phospho-eNOS as well as Akt and phospho-Akt. Parallel samples were also processed in in vitro Akt kinase assays using histone 2B as a substrate as described (5, 24) .
Insulin-stimulated Activation of eNOS Is Ca 2ϩ
-independentquent activation of eNOS. Moreover, this phosphorylation-dependent activation was independent of Ca 2ϩ , because pretreatment with BAPTA (sufficient to block LPA-mediated activation of eNOS) had no significant effect on the ability of insulin to stimulate phosphorylation of Akt or activation of eNOS. Importantly, these results were generalizable to vascular endothelial cells in primary culture.
Activation of Akt per se was not sufficient to stimulate production of NO, because PDGF treatment resulted in phosphorylation and activation of Akt without inducing phosphorylation or activation of eNOS. This phenomenon may be related to the organization of signaling microdomains and the requirement for localization of specific signaling molecules to appropriate subcellular compartments (3). Moreover, additional signaling pathways activated by insulin, but not by PDGF, may be required for stimulation of eNOS activity. Similar results have previously been observed with regard to insulin-and PDGFstimulated activation of PI 3-kinase and metabolic actions in adipose cells (3) . That is, PI 3-kinase is necessary, but not sufficient, for insulin-stimulated translocation of GLUT4 in adipocytes. by Akt (20 -22) and nucleotide-dependent protein kinases (38, 39) suggest that Ca 2ϩ /calmodulin and phosphorylation have coordinate roles in regulating the activity of eNOS. A mutant eNOS with Asp substituted for Ser at position 1179 (to mimic phosphorylation at that site) increased both catalytic activity and sensitivity to Ca 2ϩ /calmodulin (40) . Moreover, Akt can be activated by CaM-K kinase in some cells (41) . Indeed, both mobilization of intracellular Ca 2ϩ and phosphorylation of eNOS at Ser 1179 appear to be necessary for complete activation of eNOS in response to VEGF or estrogen stimulation (20, (42) (43) (44) . With respect to estrogen, the requirement for increased intracellular Ca 2ϩ is controversial, because other studies claim that the effects of estrogen in acutely activating eNOS are independent of changes in intracellular Ca 2ϩ (16) . Indeed, a number of studies suggest that Ca 2ϩ -independent regulation of eNOS activity can occur in response to a variety of stimuli including IGF-1 and shear stress (15, 17, 18, 39) . Finally, bradykinin stimulates production of NO in endothelial cells by a Ca 2ϩ -dependent mechanism (45) that does not appear to require activation of Akt (46) . Thus, different agonists may employ specific and distinct mechanisms to activate eNOS. In some cases, the requirement for increased intracellular Ca 2ϩ and phosphorylation of eNOS by Akt are linked. In other cases, increased intracellular Ca 2ϩ by itself or phosphorylation of eNOS by Akt alone may be sufficient to fully activate eNOS.
Under our experimental conditions, the magnitudes of the increases in intracellular NO elicited by LPA and insulin were comparable, although the dynamics were distinctly different. LPA stimulated a fast rise and slower decay in NO, whereas insulin stimulated a slightly slower rise in NO, with a rapid decay consistent with a distinct mechanism for activation of eNOS. The time course of NO production we observed in response to LPA was consistent with the rapid (within 10 s) increase in intracellular calcium previously observed in human skin fibroblasts upon LPA treatment (47) . In our experiments, FIG. 8 . Insulin-and LPA-stimulated activation of eNOS in vascular endothelial cells. A, untransfected HUVEC were cultured and loaded with DAF-2 as described under "Materials and Methods." The time course of relative green fluorescence intensity after LPA (5 M, f) and insulin (500 nM, OE) treatment was determined as described in the legend to Fig. 2 and plotted as the mean Ϯ S.E. of seven independent experiments (5-10 cells were chosen for each experiment). B, the time course of relative green fluorescence intensity after sequential LPA (f) and insulin (OE) treatment was plotted as the mean Ϯ S.E. of three independent experiments in untransfected HUVEC loaded with DAF-2 and pretreated with BAPTA (10 M, 20 min). C, HUVEC transiently cotransfected with pCIS2-RFP and eNOS-S1179A were loaded with DAF-2 DA and sequentially treated with LPA (f) and insulin (OE). The time course of relative green fluorescence intensity in transfected cells (identified by expression of RFP) during sequential LPA and insulin treatment was plotted as the mean Ϯ S.E. of three independent experiments. D, HUVEC transiently cotransfected with pCIS2-RFP and Akt-AAA were treated as described above, and the time course of relative green fluorescence intensity in transfected cells during sequential LPA (f) and insulin (OE) treatment was plotted as the mean Ϯ S.E. of three independent experiments.
Insulin-stimulated Activation of eNOS Is Ca 2ϩ -independent
BAPTA pretreatment was sufficient to completely block the LPA response without affecting the ability of insulin to phosphorylate and activate both Akt and eNOS in the same cells. Thus, increases in intracellular Ca 2ϩ do not appear to be required for insulin to fully activate eNOS by an Akt-dependent mechanism. Moreover, the ability of intracellular Ca 2ϩ to regulate eNOS activity was completely separable from the regulation by Akt phosphorylation. LPA did not stimulate phosphorylation of either Akt or eNOS. In addition, LPA was capable of fully activating eNOS-S1179A. Moreover, even though the antiapoptotic effects of LPA in fibroblasts and Schwann cells require Akt (48, 49) , expression of inhibitory mutants of Akt (Akt-K179A or Akt-AAA) in either HUVEC or NIH-3T3 IR cells coexpressing eNOS was unable to block activation of eNOS by LPA (in contrast with the response to insulin). We have previously demonstrated that overexpression of Akt-K179A inhibits the kinase activity of wild-type Akt in endothelial cells (5) and that both Akt-K179A and Akt-AAA mutants inhibit endogenous Akt function (25) .
Conclusions-We conclude that insulin activates eNOS by a Ca 2ϩ -independent mechanism involving phosphorylation of eNOS at Ser 1179 by Akt. The Ca 2ϩ -dependent and phosphorylation-dependent mechanisms regulating eNOS activity are completely separable in both human vascular endothelial cells and fibroblasts coexpressing insulin receptors and eNOS. The existence of two separable independent mechanisms for regulation of eNOS activity may facilitate the convergence of disparate signaling pathways on eNOS and contribute to the regulation of interdependent homeostatic processes such as metabolism and hemodynamics.
